Report for: Biologics, colchicine, corticosteroids, immunosuppressants and interferon-alpha for Neuro-Behçet's Syndrome

Title	Biologics, colchicine, corticosteroids, immunosuppressants and interferon-alpha for Neuro-Behçet's Syndrome
Published in	Cochrane database of systematic reviews, December 2014
DOI	10.1002/14651858.cd010729.pub2
Pubmed ID	25521793
Authors	Francesca Nava, Francesca Ghilotti, Lorenzo Maggi, Gulen Hatemi, Alessandra Del Bianco, Chiara Merlo, Graziella Filippini, Irene Tramacere
Abstract	Neuro-Behçet Syndrome (NBS) is a severe chronic inflammatory vascular disease involving the Central Nervous System (CNS), and it is an invalidating condition with disability and a huge impact on quality of life. Recommendations on treatments for NBS include the use of disease-modifying therapies in general, although they are not supported by a systematic review of the evidence.

View on publisher site Alert me about new mentions

Mendeley readers

The data shown below were compiled from readership statistics for 116 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country	Count	As %
United Kingdom	1	<1%
United States	1	<1%
Unknown	114	98%

Demographic breakdown

Readers by professional status	Count	As %
Student > Bachelor	20	17%
Student > Master	13	11%
Student > Ph. D. Student	12	10%
Researcher	8	7%
Student > Postgraduate	7	6%
Other	16	14%
Unknown	40	34%

Readers by discipline	Count	As %
Medicine and Dentistry	43	37%
Nursing and Health Professions	7	6%
Psychology	6	5%
Biochemistry, Genetics and Molecular Biology	4	3%
Pharmacology, Toxicology and Pharmaceutical Science	3	3%
Other	9	8%
Unknown	44	38%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 December 2014.

All research outputs

#7,454,427

of 22,789,566 outputs

Outputs from Cochrane database of systematic reviews

#8,943

of 12,314 outputs

Outputs of similar age

#105,503

of 353,354 outputs

Outputs of similar age from Cochrane database of systematic reviews

#217

of 279 outputs

Altmetric has tracked 22,789,566 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.

So far Altmetric has tracked 12,314 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.4. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,354 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.

We're also able to compare this research output to 279 others from the same source and published within six weeks on either side of this one. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.

Cochrane Database of Systematic Reviews

Biologics, colchicine, corticosteroids, immunosuppressants and interferon-alpha for Neuro-Behçet's Syndrome

About this Attention Score

Mentioned by

Citations

Readers on

Mendeley readers

Geographical breakdown

Demographic breakdown

Attention Score in Context